Sabine Herold is the Managing Director of Herold-Consulting and Herold Healthcare. We bring together experts and strong partners to provide efficient and comprehensive medical management.
Growth with Substance for MedTech, Life Science, Dental, Biotech & Pharma
Consultant and Interim Executive | Go-to-Market & Revenue Expert
I accelerate growth in an operational, team-oriented, and sustainable way. With over 25 years of leadership experience in MedTech, diagnostics, life science, dental, biotech, and pharma, I step directly into critical projects, lead teams, and build high-performance sales systems to successfully conquer complex global markets. My practical, tailored approach is supported by a strong network spanning B2B to B2C — for both corporations and startups.
My Services:
My Strengths:
Specialist in Medical Devices and Life Science
Partner of Herold- Consulting Group
Jane Reedy has over 25 years of life science experience as a business advisor and corporate executive. She is Founder of BayRock Medtech Advisors, a consultancy addressing strategic and operational matters in high potential science- and technology-based companies. Areas of expertise encompass overall business strategy, reimbursement, clinical affairs, sales and marketing, including market research. Jane is an active participant in the entrepreneurial world and lives in the San Francisco Bay Area.
Jane works with clients to enhance their competitiveness and create sustainable value by addressing critical strategic and business issues. Client engagements include market and product assessments, portfolio and therapeutic areas strategies,product development, business plans, clinical trial design and execution, competitive analysis, pricing, reimbursement and market access strategies.
Clients span the globe and include companies with a thousand employees to start-ups with fewer than three employees.
Jane works in close cooperation with Herold- Consulting, please click on http://bayrockadvisors.com.
a- medica
Partner of Herold- Consulting
Michael has implemented large corporate financial transactions in the Nordic countries as representative for Credit Lyonnais banking group.
As Director of Pierrel, a listed pharmaceutical group, Michael conducted a major restructuring. As board member for a joint-venture with Nutricia Michael also supervised market developments in enteral clinical nutrition.
Michael established and managed a coordination center for Nobel Industries group's engineering, fine chemical and pharma operations.
As Director for Developmental Technologies, a contract-research center, Michael conducted operational restructuring with the divestment of the company.
Since 1991 Michael has designed and implemented a range of accelerated business development and venture processing projects, through creative strategies for European markets, including pharmaceuticals, laboratory consumables, diagnostic tests and medical devices.
Michael is a Civilekonom from the Stockholm School of Economics.